Publications

SNAC values the open sharing of scientific knowledge. We regularly publish the findings of our research in respected journals and contribute to international academic meetings such as MICCAI, ISMRM, and ECTRIMS. We have deep collaborations with academics at the University of Sydney’s Brain and Mind Centre and with other imaging centres across the globe.

Journal Papers

Deep Learning Distinguishes Focal Epilepsy Groups Using Connectomes: Feasibility and Clinical Implications

Maher C, Tang Z, D'Souza A, Cabezas M, Cai W, Barnett M, Kavehei O, Wang C, Nikpour A

medRxiv (2023)

Improving Multiple Sclerosis Lesion Segmentation Across Clinical Sites: A Federated Learning Approach with Noise-Resilient Training.

Bai L, Wang D, Barnett M, Cabezas M, Cai W, Calamante F, Kyle K, Liu D, Ly L, Nguyen A, Shieh CC

arXiv preprint (2023)

Seizure Detection with Reduced Electroencephalogram Channels: Research Trends and Outlook

Maher C, Yang Y, Truong ND, Wang C, Nikpour A, Kavehei O

Royal Society Open Science (2023)

Real World Validation of an AI-based CT Hemorrhage Detection Tools

Wang D, Jin R, Shieh CC, Ng AY, Pham H, Dugal T, Barnett M, Winoto L, Wang C, Barnett Y

Frontiers in Neurology (2023)

Short-term Surrogate Biomarkers of Chronic Lesion Expansion

Klistorner S, Barnett M, Parratt J, Yiannikas C, Klistorner A

medRxiv (2023)

AI-based MRI Monitoring in Multiple Sclerosis: Real-World Clinical Validation

Barnett M, Wang D, Beadnall H, Bischof A, Brunacci D, Butzkueven H, Brown W, Cabezas M, Das T, Dugal T, Guilfoyle D

medRxiv (2023)

Learning from Pseudo-labels: Deep Networks Improve Consistency in Longitudinal Brain Volume Estimation

Zhan G, Wang D, Cabezas M, Bai L, Kyle K, Ouyang W, Barnett M, Wang C

Frontiers in Neuroscience (2023)

Choroid Plexus Volume Is Enlarged in Clinically Isolated Syndrome Patients with Optic Neuritis

Klistorner S, Van der Walt A, Barnett MH, Butzkueven H, Kolbe S, Parratt J, Yiannikas C, Klistorner A

Multiple Sclerosis Journal (2023)

Tremor Suppression Following Treatment with MRgFUS: Skull Density Ratio Consistency and Degree of Posterior Dentatorubrothalamic Tract Lesioning Predicts Long-term Clinical Outcomes in Essential Tremor

Kyle K, Maller J, Barnett Y, Jonker B, Barnett M, D’Souza A, Calamante F, Maamary J, Peters J, Wang C, Tisch S

Frontiers in Neurology (2023)

Multiple Sclerosis Lesion Segmentation: Revisiting Weighting Mechanisms for Federated Learning

Liu D, Cabezas M, Wang D, Tang Z, Bai L, Zhan G, Luo Y, Kyle K, Ly L, Yu J, Shieh CC

Frontiers in Neuroscience (2023)

DAMS-Net: A Domain Adaptive Lesion Segmentation Framework in Patients with Multiple Sclerosis from Multiple Imaging Centers

Liu D, Cabezas M, Zhan G, Wang D, Ly L, Kyle K, Beadnall H, Butzkueven H, Van Der Walt A, Gresle M, Buzzard K

American Academy of Neurology (2022)

Multiple Sclerosis Lesion Analysis in Brain Magnetic Resonance Images: Techniques and Clinical Applications

Ma Y, Zhang C, Cabezas M, Song Y, Tang Z, Liu D, Cai W, Barnett M, Wang C

IEEE Journal of Biomedical and Health Informatics (2022)

Decompose to Adapt: Cross-domain Object Detection via Feature Disentanglement

Liu D, Zhang C, Song Y, Huang H, Wang C, Barnett M, Cai W

IEEE Transactions on Multimedia (2022)

Rest-activity Rhythms and Tract Specific White Matter Lesions in Older Adults at Risk for Cognitive Decline

Palmer J R, Wang C, Kong D, Cespedes M, Pye J, Hickie I B, Barnett M, Naismith S L

Molecular Psychiatry (2022)

The Expansion and Severity of Chronic MS Lesions Follows a Periventricular Gradient

Klistorner S, Barnett M H, Graham S L, Wang C, Klistorner A

Multiple Sclerosis Journal (2022)

A Robust Framework for Characterising Diffusion Metrics of the Median and Ulnar Nerves: Exploiting State-of-the-Art Tracking Methods

D'Souza A, Wang C, Tu S, Soligo D J, Kiernan M C, Barnett M, Calamante F

Journal of the Peripheral Nervous System (2022)

FOD-Net: A Deep Learning Method for Fiber Orientation Distribution Angular Super Resolution

Zeng R, Lv J , Wang He, Zhou L, Barnett M, Calamante F, Wang C

Medical Image Analysis (2022)

Estimating Lesion Activity Through Feature Similarity: A Dual Dath UNet Approach for the MSSEG2 MICCAI Challenge: MSSEG-2 Challenge Proceedings

Cabezas M, Luo Y, Kyle K, Ly L, Wang C, Barnett M

MSSEG-2 Challenge Proceedings: Multiple Sclerosis New Lesions Segmentation Challenge using a Data Management and Processing Infrastructure (2021)

Brain Atrophy and Lesion Burden are Associated with Disability Progression in a Multiple Sclerosis Real-world Dataset using only T2-FLAIR: The NeuroSTREAM MSBase Study

Barnett M, Bergsland N, Weinstock-Guttman B , Butzkueven H , Kalincik T , Desmond P , Gaillard F, van Pesch V , Ozakbas S, Ignacio Rojas J , Boz C, Altintas A , Wang C, Dwyer M G, Yang S, Jakimovski D, Kyle K, Ramasamy D P, Zivadinov R

NeuroImage: Clinical (2021)

Multiple Sclerosis: Structural and Functional Integrity of the Visual System Following Alemtuzumab Therapy

Wang C, Barton J, Kyle K, Ly L, Barnett Y, Hartung H, Reddel S W, Beadnall H , Taha M, Klistorner A, Barnett M H

Journal of Neurology: Neurosurgery and Psychiatry (2021)

Interferon-β is Less Effective than Other Drugs in Controlling the Rate of Retinal Ganglion Cell Loss in MS

You Y, Barnett M H, Yiannikas C, Parratt J DE, Matthews J G, Graham S L , Klistorner A

Neurology-Neuroimmunology Neuroinflammation (2021)

Differentiating Axonal Loss and Demyelination in Chronic MS Lesions: A Novel Approach Using Single Streamline Diffusivity Analysis

Klistorner S, Barnett M H, Wasserthal J, Yiannikas C, Barton J, Parratt J, You Y, Graham S L, Klistorner A

PloS One (2021)

Latency of Multifocal Visual Evoked Potential in Multiple Sclerosis: A Visual Pathway Biomarker for Clinical Trials of Remyelinating Therapies

Alexander K, Triplett J D, Barnett M H, Yiannikas C, Barton J, Parratt J, You Y, Graham S L

Journal of Clinical Neurophysiology (2021)

Expansion of Chronic Lesions is Linked to Disease Progression in Relapsing–Remitting Multiple Sclerosis Patients

Klistorner S, Barnett M H, Yiannikas C, Barton J, Parratt J, You Y, Graham S L, Klistorner A

Multiple Sclerosis Journal (2020)

MRI Biomarkers of Disease Progression in Multiple Sclerosis: Old Dog, New Tricks?

Barnett Y, Garber J Y, Barnett M H

Quantitative Imaging in Medicine and Surgery (2020)

Regional Callosal Integrity and Bilaterality of Limb Weakness in Amyotrophic Lateral Sclerosis

Tu S, Wang C, Menke R AL, Talbot K, Barnett M, Kiernan M C, Turner M R

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2020)

Serum Exosome MicroRNAs Predict Multiple Sclerosis Disease Activity after Fingolimod Treatment

Ebrahimkhani S, Beadnall H N, Wang C, Suter C M, Barnett M H, Buckland M E, Vafaee F

Molecular Neurobiology (2020)

Salient Central Lesion Volume: A Standardized Novel Fully Automated Proxy for Brain FLAIR Lesion Volume in Multiple Sclerosis

Dwyer M G, Bergsland N, Ramasamy D P, Weinstock‐Guttman B, Barnett M H, Wang C, Tomic D, Silva D, Zivadinov R

Journal of Neuroimaging (2019)

Lesion Activity and Chronic Demyelination are the Major Determinants of Brain Atrophy in MS

Wang C, Barnett M H, Yiannikas C, Barton J, Parratt J, You Y, Graham S L, Klistorner A

Neurology-Neuroimmunology Neuroinflammation (2019)

Imaging the Multiple Sclerosis Lesion: Insights into Pathogenesis, Progression and Repair

Wang C, Barnett M, Barnett Y

Current Opinion in Neurology (2019)

Demyelination Precedes Axonal Loss in the Transneuronal Spread of Human Neurodegenerative Disease

You Y, Joseph C, Wang C, Gupta V, Liu S, Yiannikas C, Chua B E, Chitranshi N, Shen T, Dheer Y, Invernizzi A, Borotkanics R, Barnett M, Graham S L, Klistorner A

Brain (2019)

Comparing Longitudinal Brain Atrophy Measurement Techniques in a Real-world Multiple Sclerosis Clinical Practice Cohort: Towards Clinical Integration?

Beadnall H N , Wang C ,Van Hecke W , Ribbens A , Billiet T , Barnett M H

Therapeutic Advances in Neurological Disorders (2019)

Differing Structural and Functional Patterns of Optic Nerve Damage in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder

Shen T, You Y, Arunachalam S, Fontes A, Liu S, Gupta V, Parratt J, Wang C, Barnett M, Barton J, Chitranshi N

Ophthalmology (2019)

Successful Implementation of An Automated Electronic Support System for Patient Safety Monitoring: The Alemtuzumab in Multiple Sclerosis Safety Systems (AMS3) Study

Reddel S W, Barnett M H, Riminton S , Dugal T , Buzzard K, Wang C, Fitzgerald F, Beadnall H N, Erickson D, Gahan D, Wang D, Ackland T, Thompson R

Multiple Sclerosis Journal (2019)

Diffusivity in the Core of Chronic Multiple Sclerosis Lesions

Klistorner A, Wang C, Yiannikas C, Parratt J, Barton J, You Y, Graham S L, Barnett M H

PLoS One (2018)

Evidence of Progressive Tissue Loss in the Core of Chronic MS Lesions: A Longitudinal DTI Study

Klistorner A, Wang C, Yiannikas C, Parratt J, Dwyer M, Barton J, Graham S L, You Y, Liu S, Barnett M H

NeuroImage: Clinical (2018)

The Evolution of “No Evidence of Disease Activity” in Multiple Sclerosis

Lu G, Beadnall H N, Barton J, Hardy T A, Wang C, Barnett M H

Multiple Sclerosis and Related Disorders (2018)

Progression of Retinal Ganglion Cell Loss in Multiple Sclerosis is Associated with New Lesions in the Optic Radiations

Klistorner A , Graham E C, Yiannikas C, Barnett M , Parratt J , Garrick R , Wang C , You Y, Graham S L

European Journal of Neurology (2017)

MRI FLAIR Lesion Segmentation in Multiple Sclerosis: Does Automated Segmentation Hold Up with Manual Annotation?

Egger C, Opfer R, Wang C, Kepp T, Sormanie M P, Spies L , Barnett M, Schippling S

NeuroImage: Clinical (2017)

Tumefactive Demyelination Following Treatment for Relapsing Multiple Sclerosis with Alemtuzumab

Barton J, Hardy T A, Riminton S , Reddel S W, Barnett Y, Coles A, Barnett M H

Neurology (2017)

Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis

De Stefano N, Silva D G, Barnett M H

CNS Drugs (2017)

Vestibulo-ocular Reflex Deficits with Medial Longitudinal Fasciculus Lesions

Aw S T, Chen L, Todd M J, Barnett M H, Halmagyi G M

Journal of Neurology (2017)

Progressive Injury in Chronic Multiple Sclerosis Lesions Is Gender-Specific: A DTI Study

Klistorner A, Wang C, Yiannikas C, Graham S L, Parratt J, Barnett M H

PLoS One (2016)

Diffusivity in Multiple Sclerosis Lesions: At the Cutting Edge?

Klistorner A, Wang C, Fofanova V, Barnett M H, Yiannikas C, Parratt J, You Y, Graham S L

NeuroImage: Clinical (2016)

Automated Brain Volumetrics in Multiple Sclerosis: A Step Closer to Clinical Application

Wang C, Beadnall H N, Hatton S N , Bader G , Tomic D , Silva D G , Barnett H

Journal of Neurology: Neurosurgery and Psychiatry (2016)

Clinical Relevance of Brain Atrophy Assessment in Multiple Sclerosis. Implications for Its Use in a Clinical Routine

Zivadinov R, Jakimovski D, Gandhi S, Ahmed R, Dwyer MG, Horakova D, Weinstock-Guttman B, Benedict RR, Vaneckova M, Barnett M, Bergsland N

Expert Review of Neurotherapeutics (2016)

Two Time Point MS Lesion Segmentation in Brain MRI: An Expectation-Maximization Framework

Jain S, Ribbens A, Sima D M, Cambron M, De Keyser J, Wang C, Barnett M H, Van Huffel S, Maes F, Smeets D

Frontiers in Neuroscience (2016)

Radiological Differentiation of Optic Neuritis with Myelin Oligodendrocyte Glycoprotein Antibodies, Aquaporin-4 antibodies, and Multiple Sclerosis

Ramanathan S, Prelog K, Barnes E H, Tantsis E M, Reddel S W, Henderson A P, Vucic S, Gorman M P, Benson L A, Alper G, Riney C J, Barnett M H

Multiple Sclerosis Journal (2016)

Wallerian Degeneration in the Corticospinal Tract Following Tumefactive Demyelination: Conventional and Advanced Magnetic Resonance Imaging

Hardy T A, Wang C, Beadnall H N, Lagopoulos J, Barnett Y, Klistorner A, Barnett MH

Canadian Journal of Neurological Sciences (2016)

Atypical Inflammatory Demyelinating Syndromes of the CNS

Hardy T A, Reddel S W, Barnett M H, Palace J, Lucchinetti CF, Weinshenker B G

The Lancet Neurology (2016)

Decoding Diffusivity in Multiple Sclerosis: Analysis of Optic Radiation Lesional and Non-Lesional White Matter

Klistorner A, Vootakuru N, Wang C, Yiannikas C, Graham SL, Parratt J, Garrick R, Levin N, Masters L, Lagopoulos J, Barnett M H

PLoS One (2015)

Axonal Conduction in Multiple Sclerosis: A Combined Magnetic Resonance Imaging and Electrophysiological Study of the Medial Longitudinal Fasciculus

Wang C, Paling D, Chen L, Hatton S N, Lagopoulos J, Aw S T, Kiernan M C, Barnett M H

Multiple Sclerosis (2015)

Emotional Processing, P50 Sensory Gating, and Social Functioning in Bipolar Disorder

Vuillier L, Hermens D F, Chitty K, Wang C, Kaur M, Ward P B, Degabriele R, Hickie I B, Lagopoulos J

Clinical EEG and Neuroscience (2015)

Axonal Loss of Retinal Neurons in Multiple Sclerosis Associated with Optic Radiation Lesions

Klistorner A, Sriram P, Vootakuru N, Wang C, Barnett M H, Garrick R, Parratt J, Levin N, Raz N, Van der Walt A, Masters L

Neurology (2014)

Conventional and Advanced Imaging in Neuromyelitis Optica

Barnett Y, Sutton I J, Ghadiri M, Masters L, Zivadinov R, Barnett M H

American Journal of Neuroradiology (2014)

Latency of Multifocal Visual Evoked Potentials in Nonoptic Neuritis Eyes of Multiple Sclerosis Patients Associated With Optic Radiation Lesions

Alshowaeir D, Yiannikas C, Garrick R, Parratt J, Barnett M H, Graham S L, Klistorner A

Investigative Ophthalmology and Visual Science (2014)

A Topographical Relationship Between Visual Field Defects and Optic Radiation Changes in Glaucoma

Kaushik M, Graham S L, Wang C, Klistorner A

Investigative Ophthalmology and Visual Science (2014)

Relationship between Optical Coherence Tomography and Electrophysiology of the Visual Pathway in Non-Optic Neuritis Eyes of Multiple Sclerosis Patients

Sriram P, Wang C, Yiannikas C, Garrick R, Barnett M, Parratt J, Graham SL, Arvind H, Klistorner A

PLoS One (2014)

Inner Nuclear Layer Thickening Is Inversley Proportional to Retinal Ganglion Cell Loss in Optic Neuritis

Kaushik M, Wang C, Barnett M H, Garrick R, Parratt J, Graham S L, Sriram P, Yiannikas C, Klistorner A

PLoS One (2013)

The Thalamus and Multiple Sclerosis: Modern Views on Pathologic, Imaging, and Clinical Aspects

Minagar A, Barnett M H, Benedict R H, Pelletier D, Pirko I, Sahraian M A, Frohman E, Zivadinov R

Neurology (2013)

Transsynaptic Retinal Degeneration in Optic Neuropathies: Optical Coherence Tomography Study

Sriram P, Graham S L, Wang C, Yiannikas C, Garrick R, Klistorner A

Investigative Ophthalmology and Visual Science (2012)

Conference Papers/Abstracts

VISIONARY-MS Top-line Results: A Phase 2, Randomized, Double-Blind, Parallel Group, Placebo-controlled Study to Assess the Safety and Efficacy of CNM-Au8, a Catalytically Active Gold Nanocrystal Suspension in Relapsing Multiple Sclerosis

Barnett M, Beadnall H, Klistorner A, Sergott R, Greenberg B, Rynders A, Ho K, Evan J, Evan J, McBride R, Hartford A

Neurology (2023)

AI-based Characterization of Multiple Sclerosis Clinical Symptomatology Using Lesion Parenchymal Fraction: Empirical Support for the Topographical Model of MS

Krieger S, Billiet T, Maes C, De Barros N, Van Hecke W, Ribbens A, Wang T, Kyle K, Ly L, Garber J, Barnett M

Neurology (2023)

Precise Few-shot Fat-free Thigh Muscle Segmentation in T1-weighted MRI

Chen S, Tang Z, Liu D, Fornusek C, Barnett M, Wang C, Cabezas M, Cai W

International Symposium on Biomedical Imaging, Cartagena de Indias, Colombia (2023)

Global Network Disruption in Focal to Bilateral Tonic-clonic Seizures

Maher C, D'Souza A, Barnett M, Kavehei O, Nikpour A, Wang C

ISMRM 31st Annual Meeting, London, UK (2022)

Acute Global Structural and Diffusivity Changes Following Treatment with MRgFUS

Kyle K, Barnett Y, Tisch S, Jonker B, D'Souza A, Maller J, Barnett M, Maamary J, Wang C

ISMRM 31st Annual Meeting, London, UK (2022)

Towards a Personalized MRgFUS Treatment for Tremor Disorders: A Study on the Number of Ablations Using Deep Learning and Structural Connectivity

Tang Z, Cabezas M, Kyle K, D'Souza A, Tisch S, Jonker B, Barnett Y, Maamary J, Maller J, Barnett M, Cai W

ISMRM 31st Annual Meeting, London, UK (2022)

Immediate Changes in Graph Metrics Following MRgFUS – An Investigation Using State-of-the-art Diffusion Image Analysis

D'Souza A, Calamante F, Kyle K, Tisch S, Jonker B, Barnett Y, Maamary J, Maller J, Garber J, Barnett M, Wang C

ISMRM 31st Annual Meeting, London, UK (2022)

VISIONARY-MS: Update to a Phase 2 Clinical Trial of Catalytic Gold Nanocrystals, CNM-Au8, for the Treatment of Chronic Optic Neuropathy

Glanzman R L, Beadnall H, Barnett M, Klistorner A, Sergott R C, Rynders A S, Ho KS, Mortenson G, Hotchkin M T

In Multiple Sclerosis Journal, London, UK (2021)

LG-Net: Lesion Gate Network for Multiple Sclerosis Lesion Inpainting

Tang Z, Cabezas M, Liu D, Barnett M, Cai W, Wang C

International Conference on Medical Image Computing and Computer-Assisted Intervention, Strasbourg, France (2021)

Assessment of Brain Atrophy and Lesion Burden with Clinical Outcomes in Multiple Sclerosis Real-world Practice: The NeuroSTREAM MSBase Retrospective, Longitudinal Study

Barnett M, Bergsland N, Weinstock-Guttman B, Butzkueven H, Kalincik T, Desmond P, Gaillard F, Van Pesch V, Ozakbas S, Rojas J I, Boz C

Neurology (2021)

Multiple Sclerosis Lesion Filling Using a Non-lesion Attention Based Convolutional Network

Xiong H, Wang C, Barnett M, Wang C

International Conference on Neural Information Processing, Bangkok, Thailand (2020)

Masked Multi-Task Network for Case-Level Intracranial Hemorrhage Classification in Brain CT Volumes

Wang D, Wang C, Masters L, Barnett M

International Conference on Medical Image Computing and Computer Assisted Intervention, Lima, Peru (2020)

Implications of Registration of White Matter Structures for MS Connectome Analysis

Garber J, Barnett M, Calamante F, Wang C

In Multiple Sclerosis Journal, London, UK (2020)

Longitudinal Electronic Patient-reported Outcome Collection in a Treated Relapsing Multiple Sclerosis Cohort: Comparison with Clinical, Cognitive and Quantitative Magnetic Resonance Imaging Metrics

Beadnall H N, Wang C, Hardy TA, Reddel S, Barnett M H

In Multiple Sclerosis Journal, London, UK (2020)

Cortical Volume, Cortical Thickness and Cognitive Performance: Comparison of an Early Real-world Relapsing Multiple Sclerosis Cohort and Matched Healthy Controls

Beadnall H N, Wang C, Hardy T A, Reddel S, Barnett M H

In Multiple Sclerosis Journal, London, UK (2020)

VISIONARY-MS: A Phase 2 Clinical Trial Of Catalytic Gold Nanocrystals, CNM-Au8, For The Treatment Of Chronic Optic Neuropathy

Beadnall H, Hotchkin M T, Klistorner A, Barnett M, Sergott R C, Rynders A, Adamson J, Ho K S, Mortenson M G, Glanzman R

In Multiple Sclerosis Journal, London, UK (2020)

Accurate Brain Extraction Using 3D U-Net with Encoded Spatial Information

Shen H, Wang C, Kyle K, Shieh C C, Masters L, Calamante F, Tao D, Barnett M

International Society for Magnetic Resonance in Medicine 28th Annual Meeting, Paris, France (2020)

Attention-based Semantic Segmentation of Thigh Muscle with T1-weighted Magnetic Resonance Imaging

Tang Z, Kyle K, Barnett M H, Fornusek C, Cai W, Wang C

International Society for Magnetic Resonance in Medicine 28th Annual Meeting, Paris, France (2020)

Improving the Accuracy of Brain Tissue Loss Assessment in Patients with Multiple Sclerosis: A Role for Diffusion Imaging

Wang, C., A. Klistorner, H. N. Beadnall, J. Barton, L. Ly, S. Reddel, and M. H. Barnett

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Fully Automated Lesion Segmentation Using Heavily Trained 3D Convolutional Neural Networks are Equivalent to Manual Expert Segmentations

Krüger J, Opfer R, Gessert NT, Ostwaldt AC, Walker-Egger C, Manogaran P, Wang C, Barnett M, Schlaefer A, Schippling S

The European Committee For Treatment And Research In Multiple Sclerosis, Stockholm, Sweden (2019)

Magnetic Resonance Spectroscopy Correlates with DTI and Brain Atrophy in Multiple Sclerosis

Kyle K, Wang C, Beadnall H, Ghadiri M, Barnett Y, Ly L, Barnett M, Chohan G, Masters L

The European Committee For Treatment And Research In Multiple Sclerosis, Stockholm, Sweden (2019)

A Deep Learning Approach for Multiple Sclerosis T-1 Lesion-inpainting Using Non-local Partial Convolutions

Xiong H, Wang C, Tao D, Barnett M

The European Committee for Treatment and Research in Multiple Sclerosis, Stockholm, Sweden (2019)

Comparable Rates of Longitudinal Grey Matter Atrophy in Relapsing Multiple Sclerosis Patients Treated with Fingolimod and Healthy Controls Using Magnetic Resonance Imaging Analysis Techniques

Beadnall H N, Ly L, Wang C, Barton J, Hardy TA, Zivadinov R, Barnett M H

Pan-Asian Committee on Treatment and Research in Multiple Sclerosis, Paris, France (2018)

The Contribution of Subcortical Structures to Memory Impairment in Multiple Sclerosis

Devenney E, Wang T, Beadnall H, Ly L, Dawes C, Barnett M

Pan-Asian Committee on Treatment and Research in Multiple Sclerosis, Paris, France (2018)

Investigating the Mechanisms of Microstructural and Functional Changes in the Motor Pathway in Multiple Sclerosis

Garber JY, Wang C, Beadnall HN, Howells J, Matamala JM, Kiernan MC, Klistorner A, Barnett MH

Pan-Asian Committee on Treatment and Research in Multiple Sclerosis, Paris, France (2018)

Filling in the Gaps: Precision Magnetic Resonance Imaging Reporting in Multiple Sclerosis Clinical Practice

Beadnall H N, Barnett Y, Ly L, Wang C, Billiet T, Ribbens A, Van Hecke W, Masters L, Hardy T A, Barnett M H

Pan-Asian Committee on Treatment and Research in Multiple Sclerosis, Paris, France (2018)

MS-GAN: GAN-Based Semantic Segmentation of Multiple Sclerosis Lesions in Brain Magnetic Resonance Imaging

Zhang C, Song Y, Liu S, Lill S, Wang C, Tang Z, You Y, Gao Y, Klistorner A, Barnett M, Cai W

International Conference on Digital Image Computing: Techniques and Applications (2018)

Understanding Memory Impairment in Multiple Sclerosis – Contributions of Macro and Micro-structural Alterations in the Thalamus and Hippocampus

Devenney E, Wang T, Beadnall H, Ly L, Dawes C, Liu S, Barnett M

The European Committee For Treatment And Research In Multiple Sclerosis, Berlin, Germany (2018)

Alteration of Visual Cortical Microstructure is Associated with Pathology Along the Optic Radiation in Patient with MS: An Asymmetry Analysis of Posterior Visual Pathway

Wang C, Klistorner A, Barton J, Beadnall H, Ly L, Liu S, Garber J, Reddel S, Barnett M

The European Committee For Treatment And Research In Multiple Sclerosis, Berlin, Germany (2018)

Diffusivity Data Suggests Progressive Lesion-independent Demyelination in NAWM of MS Patients: A 5 Year Study

Klistorner A, Wang C, Liu S, Graham L, Barnett M

The European Committee For Treatment And Research In Multiple Sclerosis, Berlin, Germany (2018)

Personalized Lesion Profiling in Multiple Sclerosis

Liu S, Klistorner A, Wang C, Gao Y, Gilchrist B, Song Y, You Y, Yao J, Cai W, Barnett M

Joint Annual Meeting of ISMRM-ESMRMB, Paris, France (2018)

Free Water Elimination Improves Tractography through Multiple Sclerosis Lesions

Gilchrist B, Liu S, Wang C, Pasternak O, You Y, Klistorner A

Joint Annual Meeting of ISMRM- ESMRMB, Paris, France (2018)

Automatic Segmentation of Thigh Muscle in Longitudinal 3D T1-weighted Magnetic Resonance (MR) Images

Tang Z, Wang C, Hoang P, Liu S, Cai W, Soligo D, Oliver R, Barnett M, Fornusek C

In MICCAI Workshop on Data-driven Treatment Response Assessment, Granada, Spain (2018)

Improving the Accuracy of Brain Tissue Loss Assessment in Patients with Multiple Sclerosis: A Role for Diffusion Imaging

Wang, C., A. Klistorner, H. N. Beadnall, J. Barton, L. Ly, S. Reddel, and M. H. Barnett

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Centrifugal Pattern of Progressive Water Diffusion Increase in Chronic MS Lesions

Klistorner A, Wang C, Barnett M

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Long­term Disease Outcomes in Multiple Sclerosis Patients Categorised by Baseline Brain Volume and with No Disease Activity over 2 Years

Barnett MH, Silva D, Wang C, De Stefano N, Battaglini M, Sormani MP, Meinert R, Tomic D, Arnold D

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Structure and Function of the Corticospinal Tract and Motor Cortex in Multiple Sclerosis

Garber J Y, Wang C, Beadnall H N, Hardy T A, Matamala J M, Howells J, Reddel S, Kiernan M C, Barnett M H

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Multiple Sclerosis: Structure-function Correlations in the Cerebral Cortex

Beadnall H N, Wang C, Matamala J M, Hardy T A, Howells J, Dawes C, Garber J, Barton J, Reddel S, Kiernan M C, Barnett M H

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

The Effect of Quantitative Magnetic Resonance Imaging (QMRI) on No Evidence of Disease Activity (NEDA) Status in Multiple Sclerosis Clinical Practice: A Multicentre Retrospective Longitudinal Study

Beadnall H, Billiet T, Horakova D, Ramasamy D P, Ly L, Ribbens A, Dwyer M G, Uher T, Wang C, Bergsland N, Havrdova E

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Conduction Velocity in Demyelinated Cerebral White Matter: A Structure-function Correlation Study in Optic Radiation

Wang C, Barton J, Klistorner A, Ly L, Beadnall H N, Reddel S, Kiernan MC, Barnett MH

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Accelerated Loss of Chronically Demyelinated Axons in Relapsing-remitting Multiple Sclerosis

Klistorner A, Wang C, Yiannikas C, Parratt J, Barnett M

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Lateral Ventricular Atrophy Measurements Agree Better than Whole Brain Measures Across Centers and Measurement Techniques

Dwyer M, Bergsland N, Horakova D, Vaneckova M, Uher T, Havrdova E, Barnett M, Beadnall H, Wang C, Billiet T, Hecke WV

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Comparing Magnetic Resonance Imaging Brain Atrophy Measurement Techniques in Multiple Sclerosis Clinical Practice: Longitudinal Assessment

Beadnall H N, Wang C, Van Hecke W, Ribbens A, Barnett M H

Australian and New Zealand Association of Neurologists (ANZAN) Annual Scientific Meeting 2017, Gold Coast, Australia (2017)

The Prognostic Utility of No Evidence of Disease Activity (NEDA)

Lu G, Beadnall H, Wang C, Hardy T, Barton J, Barnett M

Australian and New Zealand Association of Neurologists (ANZAN) Annual Scientific Meeting, Gold Coast, Australia (2017)

Durable Reduction in MRI Disease Activity With Alemtuzumab in the Absence of Continuous Treatment in Patients With Active Relapsing-Remitting Multiple Sclerosis Who Were Treatment-Naive: 6-Year Follow-up of the CARE-MS I Study

Arnold DL, Barnett M, Comi G, Giovannoni G, Pelletier D, Rovira A, Schippling S, Van Wijmeersch B, Margolin D, Thangavelu K, Traboulsee A

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Alemtuzumab Durably Slows Brain Volume Loss Over 6 Years in the Absence of Continuous Treatment in Patients With Active RRMS Who Were Treatment-Naive (CARE-MS I) or Had an Inadequate Response to Prior Therapy (CARE-MS II)

Traboulsee A, Barnett M, Comi G, LaGanke C, Pelletier D, Rovira A, Schippling S, Margolin DH, Thangavelu K, Nakamura K, Arnold DL

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Alemtuzumab Decreased MRI Disease Activity Over 4 Years in Patients Who Switched From SC IFNB-1a: CARE-MS II Extension Study 4-Year Follow-up

Pelletier D, Barnett M, Boster A, Comi G, Hartung H P, Rovira A, Schippling S, Singer B, Traboulsee A, Margolin D H, Santra S

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Alemtuzumab Improves Clinical Outcomes Over 4 Years in Patients With Relapsing-Remitting Multiple Sclerosis Who Discontinued SC IFNB-1a: CARE-MS II Extension Study 4-Year Follow-up

Boyko A N, Barnett M, Brassat D, Dive D, Hupperts R M, Lycke J, Montalban X, Sharrack B, Wray S, Margolin D H, Thangavelu K

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Alemtuzumab Suppresses MRI Disease Activity Over 6 Years in the Absence of Continuous Treatment in Patients With Active Relapsing-Remitting Multiple Sclerosis and an Inadequate Response to Prior Therapy: CARE-MS II

Schippling S, Traboulsee A, Barnett M, Comi G, De Sèze J, Giovannoni G, Pelletier D, Rovira A, Margolin DH, Thangavelu K, Arnold DL

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Longitudinal Brain Atrophy Measurement Techniques in Clinical Multiple Sclerosis Practice Using Magnetic Resonance Imaging

Beadnall H N, Wang C, Van Hecke W, Ribbens A, Barnett M H

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Assessment of Brain Atrophy in Multiple Sclerosis Patients in Clinical Routine: A Multi-Center Comparison Study of Radiological and Quantitative Reports

Ribbens A, Billiet T, Beadnall H N, Vaneckova M, Weinstock-Guttman B, Ly L, Wang C, Carl E, Claes L, Dwyer M, Krasensky J, Uher T, Horakova D, Van Hecke W, Barnett M, Zivadinov R

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Association of Quantitative MRI to Radiological Reporting for the Evaluation of Lesion Burden Status in Multiple Sclerosis: A Multi-Center Study

Ribbens A, Billiet T, Beadnall H N, Vaneckova M, Weinstock-Guttman B, Ly L, Wang C, Ramasamy D, Houbrechts R, Bergsland N, Seidl Z, Uher T, Van Hecke W, Horakova D, Zivadinov R, Barnett M

American Academy of Neurology (AAN) Annual Meeting, Boston, USA (2017)

Alemtuzumab Reduced MRI Lesions and Slowed Brain Volume Loss in CARE-MS II Patients Switching from SC IFNB-1a: 5-year Follow-up After Alemtuzumab (TOPAZ Study)

Pelletier D, Barnett M, Boster A, Comi G, Hartung H P, Rovira A, Schippling S, Singer B V, Traboulsee A, Margolin H, Santra S

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Alemtuzumab Decreased MRI Disease Activity and Slowed Brain Volume Loss Over 5 Years After Switching From SC IFNB-1a: Follow-up of CARE-MS I (TOPAZ study)

Rovira A, Barnett M, Comi G, Nakamura K, Pelletier D, Schippling S, Traboulsee A, Margolin D H, Daizadeh N, Arnold D L

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Patients with Active RRMS Experience Durable Reductions in MRI Disease Activity and Slowing of Brain Volume Loss with Alemtuzumab: 7-year Follow-up of CARE-MS II Patients (TOPAZ Study)

Pelletier D, Traboulsee A, Barnett M, Comi G, De Seze J, Rovira A, Schippling S, Margolin D H, Santra S, Nakamura K, Arnold D L

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Silent lesions on MRI Imaging-Shifting Goal Post for Treatment Decisions in MS

Min M, Spelman T, Lugaresi A, Boz C, Spitaleri D L, Pucci E, Grand’Maison F, Granella F, Izquierdo G, Butzkueven H, Sanchez-Menoyo J L

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Durable Reduction in MRI Disease Activity and Slowing of Brain Volume Loss with Alemtuzumab in Patients with Active RRMS: 7-year Follow-up of CARE-MS I Patients (TOPAZ Study)

Arnold D L, Barnett M, Comi G, LaGanke C, Pelletier D, Rovira A, Schippling S, Margolin DH, Daizadeh N, Nakamura K, Traboulsee A

7th Joint ECTRIMS-ACTRIMS meeting, Paris, France (2017)

Arterial Spin Labelling Measurements of Cortical Perfusion in Multiple Sclerosis Show Widespread Reduced Cortical Metabolism

Oliver R, Beadnall H N, Wang C, Kiernan M, Hardy T, Barnett M

International Society for Magnetic Resonance in Medicine 25th Annual Meeting, Honolulu, USA (2017)

Optic Radiation Reconstruction in Patients with Multiple Sclerosis: Template Based Approach vs. Individual Tractography Based Method

Wang C, Klistorner A, Ly L, Fofanova V, Barnett M H

International Society for Magnetic Resonance in Medicine, Lisbon, Portugal (2016)

Quantifying Lesion Progression in Multiple Sclerosis: A Novel Magnetic Resonance Imaging Pipeline

Wang C, Ly L, Klistorner A, Beadnall H, Barton J, Oliver R, Barnett M H

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis Congress, London, UK (2016)

Automated Segmentation of FLAIR Lesion Volume and Number: Validation and Comparison to Manual Inter-rater Variability

Egger C, Opfer R, Wang C, Kepp T, Spies L, Sormani MP, Barnett M, Schippling S

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, London, UK (2016)

Diffusivity in Multiple Sclerosis Lesions: At The Cutting Edge?

Klistorner A, Wang C, Fofanova V, Barnett M H, Yiannikas C, Parratt J, You Y, Graham S L

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis Congress, London, UK (2016)

Longitudinal Assessment of Brain Lesion Changes in Follow-up MRI Scans of Patients with Multiple Sclerosis

Jain S, Ribbens A, Sima D, Cambron M, De Keyser J, Wang C, Barnett M H, Van Huffel S, Maes F, Maertens A, Smeets D

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis, London, UK (2016)

Comparison of Cortical Perfusion Between Relapse-remitting Multiple Sclerosis Patients and Healthy Controls Measured Using Arterial Spin Labeling MRI

Oliver R A, Ly L, Beadnall H, Wang C, Hardy T, Barnett M H

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis, London, UK (2016)

A Multicentre Study of Quantitative Susceptibility Mapping in Sub-cortical Deep Gray Matter Structures in Relapsing Multiple Sclerosis

Zivadinov R, Schweser F, Dawes C, Hagemeier J, Ly L, Wang C, Bergsland N, Beadnall H, Carl E, Weinstock-Guttman B, Benedict R R

32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis, London, UK (2016)

The Role of Quantitative Magnetic Resonance Imaging (QMRI) in Clinical Decision Making in Multiple Sclerosis

Beadnall H N , Ly L , Wang C, Oliver R , Lu G, Barnett M H

Australian and New Zealand Association of Neurologists (ANZAN) Annual Scientific Meeting, Perth, Australia (2016)

Whole Brain Volume Quantification in Multiple Sclerosis: Ready for Translation into Clinical Practice?

Beadnall H, Wang C, Burke T, Oliver R, Hatton S, Barton J, Ly L, Vucic S, Barnett M

American Academy of Neurology 68th Annual Meeting, Vancouver, Canada (2016)

Complete Partial Volume Solution for ASL Brain Perfusion Data Applied to Relapsing-remitting Multiple Sclerosis Patients

Oliver R, Ly L, Wang C, Beadnall H, Galazzo I B, Chappell M, Golay X, De Vita E, Thomas D, Barnett M

International Society for Magnetic Resonance in Medicine 24th Annual Meeting, Singapore (2016)

A Novel MRI Pipeline for Assessing Multiple Sclerosis Lesion Evolution in the Optic Radiation

Wang C, Klistorner A, Oliver RA, Ly L, Barnett M H

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, Barcelona, Spain (2015)

Tablet-based Waiting Room Cognitive Screening in a Multiple Sclerosis Clinic

Beadnall H N, Wang C, Benedict RH, Dawes C, Barnett M H

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, Barcelona, Spain (2015)

Evidence of Progressive Demyelination and Neurodegeneration in Chronic MS Lesions: DTI Study

Klistorner A, Yiannikas C, Parratt J, Wang C, Liu Y T, Graham SL, Barnett M H

European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) Congress, Barcelona (2015)

Degenerative Changes in the Optic Radiation and the Primary Visual Cortex in Glaucoma Patients: An MRI Study

You Y, Kaushik M, Wang C, Graham S, Klistorner A

The 6th World Glaucoma Congress, Hongkong (2015)

Quantifying Brain Atrophy: Ready for Translation to Clinical Practice?

Wang C, Beadnall H N, Burke T, Oliver R, Hatton S H, Barton J, Ly L, Vucic S, Barnett M B

Australian & New Zealand Association of Neurologists (ANZAN) Conference, Auckland, New Zealand (2015)

Whole Brain Volume Measurements in Multiple Sclerosis: Cross-Sectional Data Comparison Between Three Methods

Wang C, Beadnall H, Hatton S, Bader G, Tomic D, Silva D, Barnett M

American Academy of Neurology 67th Annual Meeting, Washington, USA (2015)

Biomarkers of Neurodegeneration in Multiple Sclerosis

Clarke A J, Wang C, Beadnall H, Ghadiri M, Chohan G, Masters L, Barnett Y, Hatton S N, Lagopoulos J, Hagemeier J, Zivadinov R, Barnett M H

Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) Congress, Taipei, Taiwan (2014)

Magnetic Resonance Spectroscopy Measurements In Normal-Appearing White Matter As A Biomarker Of Whole Brain White Matter Integrity In Relapsing Remitting Multiple Sclerosis

Hatton S N, Lagopoulos J, Wang C, Beadnall H, Ghadiri M, Chohan G, Masters L, Barnett Y, Barnett M H

7th Pan-Asian Committee for Treatment and Research in Multiple Sclerosis (PACTRIMS) Congress, Taipei, Taiwan (2014)

Medial Longitudinal Fasciculus: A Window on Axonal Function in Multiple Sclerosis

Wang C, Paling D, Chen L, Hatton S, Lagopoulos J, Aw S, Kiernan M, Barnett M

Australian & New Zealand Association of Neurologists (ANZAN) Conference, Sydney, Australia (2014)

Understanding Mechanisms of Axonal Loss in Non-Optic Neuritis Eyes of Multiple Sclerosis Patients

Klistorner A, Sriram P, Vootakuru N, Wang C, Barnett M, Garrick R, Parratt J, Levin N, Raz N, Masters L, Graham S, Yiannikas C

29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis & 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark (2013)

Inner Nuclear Layer Thinning is Proportional to the Loss of Retinal Ganglion Cells in Optic Neuritis

Kaushik M, Klistorner A, Wang C, Barnett M, Garrick R, Parratt J, Graham S, Yiannikas C

29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis & 18th Annual Conference of Rehabilitation in MS, Copenhagen, Denmark (2013)

Lesion Length Along the Medial Longitudinal Fasciculus Correlates with Neuroaxonal Conduction Delay in Multiple Sclerosis as a Whole-Brain Disease

Wang C, Paling D, Aw S, Barnett M H, Chen L, Hatton S, Lagopoulos J

International Society for Magnetic Resonance in Medicine Workshop, London, UK (2013)

Ganglion Cells Loss in Non-optic Neuritis Eyes of MS Patients

Sriram P, Saakova N, Wang C, Arvind H, Graham S, Yiannikus C, Garrick R, Barnett M, Parrett J, Klistorner A

28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Lyon, France (2012)

Retinal Structure and Function in Eyes of Multiple Sclerosis Patients with No Optic Neuritis

Sriram P , Saakova N, Wang C, Graham S, Yiannikus C , Garrick R, Klistorner A

50th International Society for Clinical Electrophysiology of Vision Symposium, Valencia, Spain (2012)